FluBlok: Clinical Trials

5 trials of FluBlok, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 unknown. 5 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 45Completed 4, Unknown 1

Follow FluBlok: new trials by email Literature Review of FluBlok trials Research Report on FluBlok

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Immunogenicity of Influenza Vaccinations
Flucelvax® (ccIIV3), Flublok® (RIV3) - Influenza
Phase 4CompletedDuke University6062024-09-092026-07-28
Dynamics of the Immune Responses to Repeat Influenza Vaccination Exposures
FluBlok, Placebo - Influenza, Human
Phase 4CompletedThe University of Hong Kong9772020-10-052026-05-15
Recombinant Influenza Vaccination in U.S. Nursing Homes
Recombinant Influenza Vaccine, Standard Dose Quadrivalent Influenza Vaccine - Influenza, Influenza -Like Illness
Phase 4UnknownInsight Therapeutics, LLC19892019-07-202023-03-15
Immunogenicity Trial of Egg- Versus Non-Egg-Based Influenza Vaccines Among HCP
Flublok, Flucelvax, Fluarix - Influenza
Phase 4CompletedCenters for Disease Control and Prevention9442018-09-122024-07-22
Comparison of Three Licensed Influenza Vaccines
FluBlok, Fluzone, FluCelVax - Influenza
Phase 4CompletedUniversity of Rochester4132015-10-282021-11-30

Conditions studied

Influenza, Human (5)

Sponsors

Centers for Disease Control and Prevention (1)  ·  Duke University (1)  ·  Insight Therapeutics, LLC (1)  ·  The University of Hong Kong (1)  ·  University of Rochester (1)

Countries

United States (4)  ·  Hong Kong (1)

Top investigators

Angela Branche, MD (1)  ·  Brendan Flannery, PhD (1)  ·  Emmanuel B Walter, MD, MPH (1)  ·  Fatimah Dawood, MD (1)  ·  H. Edward Davidson, PharmD, MPH (1)  ·  Stefan Gravenstein, MD, MPH (1)

Results publications

PMID 31598646, PMID 34245243, PMID 36031405, PMID 38177116, PMID 39041887, PMID 39745702, PMID 42856744

NIH funding

272201400005C-P00019-9999-4 (1), U01AI153700 (1)